Karin Lindahl

Karin Lindahl

UNVERIFIED PROFILE

Are you Karin Lindahl?   Register this Author

Register author
Karin Lindahl

Karin Lindahl

Publications by authors named "Karin Lindahl"

Are you Karin Lindahl?   Register this Author

14Publications

103Reads

14Profile Views

Management of hepatitis B virus infection, updated Swedish guidelines.

Infect Dis (Lond) 2019 Oct 15:1-22. Epub 2019 Oct 15.

Deparment of Infectious Diseases, Institute of Biomedicine at the Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/23744235.2019.1675903DOI Listing
October 2019

Prevalence of chronic hepatitis C virus infection among childhood cancer survivors in Stockholm, Sweden.

Acta Oncol 2019 Jul 14;58(7):997-1002. Epub 2019 Feb 14.

a Department of Clinical Science, Intervention and Technology (CLINTEC) , Karolinska Institutet , Stockholm , Sweden.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/0284186X.2019.1
Publisher Site
http://dx.doi.org/10.1080/0284186X.2019.1574105DOI Listing
July 2019

Direct acting anti-viral medications for hepatitis C: Clinical trials in patients with advanced chronic kidney disease.

Semin Dial 2019 03 26;32(2):135-140. Epub 2018 Nov 26.

Department of Medicine, Division of Infectious Diseases, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/sdi.12762
Publisher Site
http://dx.doi.org/10.1111/sdi.12762DOI Listing
March 2019

Prevalence and outcome of post-transfusion hepatitis C acquired at different ages and detected in look-back screening.

Scand J Gastroenterol 2018 Jun - Jul;53(7):870-875. Epub 2018 Jun 18.

a Department of Medicine Huddinge , Karolinska Institutet , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365521.2018.1476911DOI Listing
November 2018

Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis.

J Hepatol 2018 05 9;68(5):904-911. Epub 2017 Dec 9.

Department of Renal Medicine, CLINTEC, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.12.003DOI Listing
May 2018

High-Dose Ribavirin Enhances Early Virological Response in Hepatitis C Genotype 1-Infected Patients.

Ther Drug Monit 2015 Dec;37(6):745-50

*Division of Infectious Diseases, Department of Internal Medicine, Karolinska Institutet, Karolinska University Hospital; and †Division of Clinical Pharmacology, Department of Medical Laboratory Sciences, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/FTD.0000000000000210DOI Listing
December 2015

Strategies in health-promoting dialogues--primary healthcare nurses' perspectives--a qualitative study.

Scand J Caring Sci 2014 Jun 17;28(2):235-44. Epub 2013 Apr 17.

Department of Nursing, Umeå University, Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/scs.12045DOI Listing
June 2014

Novel method for studying photolability of topical formulations: a case study of titanium dioxide stabilization of ketoprofen.

J Pharm Sci 2005 Apr;94(4):781-7

ACO HUD AB, Box 622, SE-194 26, Upplands Väsby, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jps.20295DOI Listing
April 2005

High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C.

Hepatology 2005 Feb;41(2):275-9

Department of Infectious Diseases, Karolinska University Hospital Huddinge, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.20563DOI Listing
February 2005

Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration.

Int J Pharm 2004 Oct;284(1-2):23-30

ACO HUD AB, Box 622, SE-194 26 Upplands Väsby, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2004.07.018DOI Listing
October 2004

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

Nephrol Dial Transplant 2003 Aug;18(8):1573-80

Division of Renal Medicine, Department of Clinical Science, Karolinska Institute and Huddinge University Hospital, S-141 86 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfg209DOI Listing
August 2003

Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis.

Ther Drug Monit 2002 Dec;24(6):701-8

Division of Renal Medicine, Department of Clinical Science, Karolinska Institute and Huddinge University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00007691-200212000-00004DOI Listing
December 2002